Novartis AG (NVS)
NYSE: NVS · Real-Time Price · USD
130.40
-0.04 (-0.03%)
At close: Nov 28, 2025, 4:00 PM EST
130.70
+0.30 (0.23%)
Pre-market: Dec 1, 2025, 8:30 AM EST
Novartis AG Stock Forecast
Stock Price Forecast
The 1 analyst with a 12-month price forecast for Novartis AG stock has a target of 118, which predicts a -9.51% decrease from the current stock price of 130.4.
Price Target: $118 (-9.51%)
Analyst Consensus: Sell
* Price targets were last updated on Sep 12, 2025.
Analyst Ratings
The average analyst rating for Novartis AG stock is "Sell". This means that analysts believe this stock is likely to lead to lower returns than market as a whole.
Recommendation Trends
| Rating | Jun '25 | Jul '25 | Aug '25 | Sep '25 | Oct '25 | Nov '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 6 | 6 | 6 | 3 | 4 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 1 | 1 | 1 |
| Total | 6 | 6 | 6 | 4 | 5 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Jefferies | Jefferies | Hold Initiates n/a | Hold | Initiates | n/a | n/a | Oct 27, 2025 |
| Goldman Sachs | Goldman Sachs | Hold → Strong Sell Downgrades $119 → $118 | Hold → Strong Sell | Downgrades | $119 → $118 | -9.51% | Sep 12, 2025 |
| UBS | UBS | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Feb 13, 2025 |
| Erste Group | Erste Group | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Nov 19, 2024 |
| BMO Capital | BMO Capital | Hold Maintains $118 → $120 | Hold | Maintains | $118 → $120 | -7.98% | Oct 30, 2024 |
Financial Forecast
Revenue This Year
56.60B
from 51.72B
Increased by 9.44%
Revenue Next Year
58.11B
from 56.60B
Increased by 2.65%
EPS This Year
9.13
from 5.87
Increased by 55.60%
EPS Next Year
9.44
from 9.13
Increased by 3.34%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 60.9B | 63.7B | |||
| Avg | 56.6B | 58.1B | |||
| Low | 53.6B | 53.1B |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 17.7% | 12.5% | |||
| Avg | 9.4% | 2.7% | |||
| Low | 3.7% | -6.2% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 9.77 | 10.92 | |||
| Avg | 9.13 | 9.44 | |||
| Low | 8.54 | 8.09 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 66.4% | 19.6% | |||
| Avg | 55.6% | 3.3% | |||
| Low | 45.4% | -11.5% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.